NASDAQ:PRVB

Provention Bio, Inc.

Stock

USD

Last Close

24.98

26/04 20:00

Market Cap

2.38B

Beta: 2.46

Volume Today

9.12M

Avg: 2.81M

PE Ratio

−16.52

PFCF: −31.17

Overview Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22
average inventory							615.50K -
average payables		229.87K -	513.87K 123.55%	1.17M 127.97%	4.67M 298.76%	5.56M 18.96%	5.15M 7.26%
average receivables							679.50K -
book value per share		0.59 -	2.66 346.98%	-1.94 172.99%	-3.39 74.53%	-4.63 36.68%	1.63 135.23%
capex per share					-0.02 -	-0.02 28.09%	-0.01 30.14%
capex to depreciation					-33.67 -	-2.48 92.62%	-0.65 73.93%
capex to operating cash flow					0.01 -	0.01 30.78%	0.01 4.64%
capex to revenue						-0.69 -	-0.06 91.05%
cash per share		0.64 -	2.61 304.80%	2.10 19.68%	2.32 10.84%	1.51 35.10%	2.21 46.50%
days of inventory on hand							877.57 -
days payables outstanding							4.82K -
days sales outstanding							38.47 -
debt to assets	2.32 -	0.10 95.62%	0.03 70.04%	0.04 46.84%	2.38 5,234.94%	0.18 92.30%	0.49 164.60%
debt to equity	-1.76 -	0.11 106.42%	0.03 72.24%	-0.05 254.87%	-1.72 3,448.42%	-0.09 95.06%	0.94 1,207.70%
dividend yield
earnings yield		-0.06 -	-0.67 1,089.48%	-0.07 89.57%	-0.11 59.61%	-0.32 190.87%	-0.14 55.44%
enterprise value		141.14M -	-18.82M 113.33%	567.97M 3,118.13%	787.04M 38.57%	277.03M 64.80%	769.69M 177.84%
enterprise value over ebitda		-15.45 -	0.71 104.57%	-12.80 1,913.72%	-7.90 38.32%	-2.40 69.64%	-6.17 157.53%
ev to operating cash flow		-28.91 -	0.83 102.87%	-15.75 1,994.82%	-10.31 34.53%	-2.90 71.83%	-10.21 251.44%
ev to sales						198.59 -	59.69 69.94%
free cash flow per share		-0.14 -	-1.01 600.28%	-0.89 12.28%	-1.48 66.81%	-1.53 3.42%	-1.02 33.21%
free cash flow yield		-0.03 -	-0.57 1,803.02%	-0.06 89.58%	-0.09 46.72%	-0.27 211.73%	-0.10 64.49%
graham net net		0.58 -	2.53 337.48%	2.00 20.76%	-3.51 275.62%	1.11 131.67%	0.69 37.91%
graham number		1.90 -	8.40 342.32%	6.72 19.96%	11.97 77.96%	13.74 14.85%	7.47 45.66%
income quality		0.53 -	0.86 59.99%	0.83 2.56%	0.77 7.06%	0.83 7.65%	0.66 20.34%
intangibles to total assets	0 -	0	0	0	0	0	0.25 Infinity%
interest coverage					161.83 -	791.63 389.18%	-123.59 115.61%
interest debt per share					0.00 -	0.01 272.83%	0.33 4,644.79%
inventory turnover							0.42 -
invested capital					-0.00 -	-0.00 49.81%	0.20 9,814.01%
market cap		162.97M -	39.72M 75.63%	607.13M 1,428.50%	888.62M 46.36%	354.63M 60.09%	789.82M 122.72%
net current asset value	-164.71K -	20.15M 12,334.75%	59.66M 196.05%	82.16M 37.71%	-179.61M 318.62%	76.21M 142.43%	59.64M 21.74%
net debt to ebitda		2.39 -	2.20 8.17%	0.88 59.79%	1.02 15.45%	0.67 34.11%	0.16 75.96%
net income per share		-0.27 -	-1.18 337.71%	-1.04 12.23%	-1.88 81.47%	-1.81 3.50%	-1.52 16.19%
operating cash flow per share		-0.14 -	-1.01 600.28%	-0.89 12.28%	-1.46 64.41%	-1.51 3.88%	-1.01 33.24%
payables turnover							0.08 -
receivables turnover							9.49 -
research and ddevelopement to revenue						49.91 -	5.88 88.22%
return on tangible assets		-0.41 -	-0.43 5.68%	-0.49 14.03%	-0.77 56.32%	-0.84 10.00%	-0.64 24.09%
revenue per share						0.02 -	0.17 680.60%
roe		-0.45 -	-0.44 2.07%	0.53 220.26%	0.55 3.97%	0.39 29.40%	-0.93 337.89%
roic		0.42 -	0.47 12.65%	-7.34 1,647.62%	1.19 116.15%	4.71 297.61%	-0.81 117.12%
sales general and administrative to revenue						33.94 -	4.97 85.35%
shareholders equity per share		0.59 -	2.66 346.98%	-1.94 172.99%	-3.39 74.53%	-4.63 36.68%	1.63 135.23%
stock based compensation to revenue						8.49 -	1.48 82.61%
tangible asset value	-164.71K -	20.15M 12,334.75%	59.66M 196.05%	82.16M 37.71%	-177.64M 316.23%	110.73M 162.34%	62.29M 43.75%
tangible book value per share		0.59 -	2.66 346.98%	2.02 24.16%	-3.39 267.96%	1.75 151.82%	0.83 52.50%
working capital	-164.71K -	21.15M 12,940.68%	59.66M 182.08%	82.16M 37.71%	109.82M 33.68%	78.31M 28.70%	84.26M 7.60%

All numbers in USD (except ratios and percentages)